Inhibition of STIM1-mediated Ca2+ entry, by a pharmacological inhibitor SKF96365 or by siRNA-mediated silencing of STIM1 or Orai1, caused the impairment of the focal adhesion turnover and invasive migrations of breast cancer cells21. Here, STIM1 is linked to breast cancer.